We are live on ! Find out more
HKIM

Hayek Kallen Investment Management Portfolio holdings

AUM $307M
1-Year Est. Return 18.5%
This Fund
S&P 500
This Quarter Est. Return
+3.27%
1 Year Est. Return
+18.5%
3 Year Est. Return
+68.46%
5 Year Est. Return
+97.89%
10 Year Est. Return
+297.02%
AUM
$139M
AUM Growth
+$4.32M
Cap. Flow
+$599K
Cap. Flow %
0.43%
Top 10 Hldgs %
37.64%
Holding
61
New
4
Increased
16
Reduced
32
Closed
1

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$413K
2
JNJ icon
Johnson & Johnson
JNJ
+$202K
3
SO icon
Southern Company
SO
+$166K
4
GE icon
GE Aerospace
GE
+$158K
5
MO icon
Altria Group
MO
+$148K

Sector Composition

Rank Sector Weight
1 Healthcare 22.15%
2 Consumer Staples 19.16%
3 Technology 16.56%
4 Industrials 11.02%
5 Communication Services 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.14T
$6.65M 4.78%
45,946
-712
-2% -$102K
VZ icon
2
Verizon
VZ
$195B
$5.97M 4.29%
106,960
-2,365
-2% -$123K
XOM icon
3
ExxonMobil
XOM
$662B
$5.95M 4.27%
63,455
+230
+0.4% +$20.3K
MSFT icon
4
Microsoft
MSFT
$3.76T
$5.55M 3.99%
108,504
-1,752
-2% -$91K
JNJ icon
5
Johnson & Johnson
JNJ
$631B
$5.36M 3.85%
44,194
-1,776
-4% -$202K
TMO icon
6
Thermo Fisher Scientific
TMO
$222B
$4.95M 3.55%
33,481
-943
-3% -$139K
GE icon
7
GE Aerospace
GE
$380B
$4.7M 3.38%
31,166
-1,086
-3% -$158K
AAPL icon
8
Apple
AAPL
$4.5T
$4.64M 3.33%
194,200
+1,852
+1% +$46K
WM icon
9
Waste Management
WM
$90.6B
$4.37M 3.14%
65,943
-900
-1% -$54.4K
INTC icon
10
Intel
INTC
$492B
$4.29M 3.08%
130,916
-535
-0.4% -$16.8K
MO icon
11
Altria Group
MO
$109B
$4.29M 3.08%
62,186
-2,316
-4% -$148K
PM icon
12
Philip Morris
PM
$290B
$4.26M 3.06%
41,857
-1,240
-3% -$124K
KO icon
13
Coca-Cola
KO
$374B
$4.2M 3.01%
92,586
-1,089
-1% -$49.2K
NVS icon
14
Novartis
NVS
$298B
$4.12M 2.96%
55,730
+759
+1% +$52.4K
CHL
15
DELISTED
China Mobile Limited
CHL
$3.9M 2.8%
67,379
-1,750
-3% -$98.4K
TAP icon
16
Molson Coors Class B
TAP
$7.93B
$3.78M 2.72%
37,413
-392
-1% -$38.5K
WMT icon
17
Walmart Inc
WMT
$897B
$3.76M 2.7%
154,383
-876
-0.6% -$20.3K
T icon
18
AT&T
T
$165B
$3.59M 2.58%
110,055
+1,361
+1% +$40.5K
TEVA icon
19
Teva Pharmaceuticals
TEVA
$42.1B
$3.54M 2.54%
70,486
+3,251
+5% +$173K
MCD icon
20
McDonald's
MCD
$194B
$3.33M 2.39%
27,631
-908
-3% -$114K
PEP icon
21
PepsiCo
PEP
$188B
$3.13M 2.24%
29,509
-893
-3% -$92.2K
RTX icon
22
RTX Corp
RTX
$302B
$3.08M 2.21%
47,734
-1,759
-4% -$113K
PFE icon
23
Pfizer
PFE
$154B
$3.05M 2.19%
91,202
+1,537
+2% +$49.1K
NVO
24
Novo Nordisk
NVO
$211B
$3.01M 2.16%
111,830
-1,100
-1% -$30.2K
UNP icon
25
Union Pacific
UNP
$174B
$2.9M 2.08%
33,235
+1,699
+5% +$144K

Similar funds

Hayek Kallen Investment Management's Q2 2016 Portfolio in Review

As of Q2 2016, Hayek Kallen Investment Management held 61 positions worth $139M, up 3.2% from $135M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Hayek Kallen Investment Management's Q2 2016 filing shows 4 new, 16 increased, 32 reduced and 1 closed positions. Its largest new stake was Carnival Corporation Ltd: 10,000 shares worth $442K. The largest sale was Exelon, an estimated $413K.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Technology.

  • Hayek Kallen Investment Management's largest Q2 2016 buy was Carnival Corporation Ltd: 10,000 shares worth $442K.
  • Hayek Kallen Investment Management added most to Icon in Q2 2016, an estimated $474K increase.
  • Hayek Kallen Investment Management's biggest Q2 2016 reduction was Johnson & Johnson, cutting an estimated $202K.
  • Hayek Kallen Investment Management fully exited Exelon in Q2 2016, selling an estimated $413K.
  • Hayek Kallen Investment Management's ten largest holdings make up 38% of its $139M portfolio in Q2 2016.
  • Hayek Kallen Investment Management opened 4 new positions and closed 1 in Q2 2016.
  • Hayek Kallen Investment Management's portfolio value rose 3.2% quarter-over-quarter to $139M.

Based on Hayek Kallen Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.